Why Nestle is acting like a drug company

03/22/2016 -Cambridge, MA- (left - right) Stefan Catsicas, (cq) Global Head of Research and Development at Nestlé, left, and Greg Behar, (cq) CEO of Nestlé Health Science , right, pose for a portrait during an interview at the Charles Hotel in Cambridge, MA on March 22, 2016. (Craig F. Walker/Globe Staff) section: Business reporter: Ambrose
Nestlé, the global food behemoth known for selling chocolate and frozen pizza, has been acting a lot like a big drug company lately.

Its Nestlé Health Science subsidiary, which develops nutritional products to improve health, is pouring money into companies targeting conditions like gut infections, muscle loss, and Alzheimer’s disease. It just opened an outpost in the biotech hub of Kendall Square.

And CEO Greg Behar, who took charge of the subsidiary in 2014 after more than a decade in the pharmaceutical industry, spent three days last week in the Boston area last week, in part to scout biotech companies as investment targets. He said he’s looking for startups with strong management and good science in fields such as brain and gastrointestinal health.

“As long as we find those, we’ll continue to invest,” read more here

Leave a Reply

Your email address will not be published. Required fields are marked *

Home / Home Right / Why Nestle is acting like a drug company